Buckner, Jan C <br/><br/>
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 2003 
 - 251-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2003.06.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Astrocytoma--drug therapy<br/>Brain Neoplasms--drug therapy<br/>Chromosome Aberrations<br/>Chromosome Deletion<br/>Chromosomes, Human, Pair 1--genetics<br/>Chromosomes, Human, Pair 19--genetics<br/>Female<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Lomustine--therapeutic use<br/>Male<br/>Middle Aged<br/>Oligodendroglioma--drug therapy<br/>Procarbazine--therapeutic use<br/>Prognosis<br/>Radiotherapy, Adjuvant<br/>Vincristine--therapeutic use